Delivery Order SPE2DB22D2005-SPE2DB25FJRB0
- Not listed
- The Defense Logistics Agency awarded a $1,577.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for IYUZEH 0.005% eye drops on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-competitive delivery order will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The contract represents a small-value transaction typical of routine pharmaceutical procurement through the federal medical supply chain supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,222.87 to AmerisourceBergen Drug Corp for the supply of IYUZEH 0.005% eye drop medication. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $2,555.92 delivery order from the Defense Logistics Agency (DLA) on August 7, 2025, for MIEBO 100% eye drop solution in 3 milliliter quantities. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing under a child delivery order mechanism. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,649.80 to AmerisourceBergen Drug Corp for Lubricant 0.5% Eye Drop (30 units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- The Defense Logistics Agency awarded a delivery order valued at $8,723.79 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract, valued at $1,158.74, is for the supply of IYUZEH 0.005% eye drops. The contract is a firm fixed-price, non-set-aside award with a performance period through June 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRB0Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $6,758.72 to AmerisourceBergen Drug Corp for IYUZEH 0.005% eye drops. This competitively awarded contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a pediatric pharmaceutical supply supporting federal medical procurement needs. The delivery order was fulfilled from AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, which serves as the place of performance. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with DLA covering diverse therapeutic domains, consistently demonstrating capability to meet federal procurement requirements through open competition without set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/7/25 |